Ischemic Hepatitis Before and During Venoarterial Extracorporeal Membrane Oxygenation: Associations with In-Hospital Mortality
Journal of Cardiovascular Development and Disease · 11.11.2026 · 13 (11) · 583
DOI: 10.3390/jcdd13110583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 11.11.2026. Verfasst von Gözde Tekin und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatic dysfunction is associated with adverse outcomes in patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO). However, the clinical significance of ischemic hepatitis (IH) identified before versus during ECMO support remains uncertain. We investigated the association between IH categories and in-hospital outcomes in patients receiving VA-ECMO.
Methods
We retrospectively analyzed 182 adult patients receiving VA-ECMO between 2019 and 2025, including 159 surgical and 23 nonsurgical patients. Patients were classified as having no IH (n = 71), pre-ECMO IH (n = 47), or on-ECMO IH (n = 64). The primary outcome was in-hospital mortality.
Results
In-hospital mortality was 71.8%, 85.1%, and 89.1% in the no IH, pre-ECMO IH, and on-ECMO IH groups, respectively (overall p = 0.028). ECMO weaning success rates were 57.7%, 27.7%, and 34.4%, respectively (p = 0.002). In multivariable logistic regression adjusted for age, hypertension, baseline left ventricular ejection fraction, and estimated glomerular filtration rate, on-ECMO IH was associated with higher odds of in-hospital mortality compared with no IH (adjusted OR 4.019, 95% CI 1.453–11.112; p = 0.007). The corresponding association for pre-ECMO IH was not statistically significant (adjusted OR 2.213, 95% CI 0.785–6.241; p = 0.133). However, the direct adjusted comparison between on-ECMO IH and pre-ECMO IH was not statistically significant (adjusted OR 1.816, 95% CI 0.543–6.072; p = 0.333).
Conclusions
Ischemic hepatitis identified during VA-ECMO support was associated with increased in-hospital mortality compared with the absence of IH. However, no statistically significant difference was demonstrated between pre-ECMO and on-ECMO IH. These findings should be interpreted cautiously given the retrospective classification of IH and potential temporal bias.
Zitieren
APA
Tekin, G., Demirbaş, Z. E., Elçi, M. E., & Yılmaz, Ş. (2026). Ischemic Hepatitis Before and During Venoarterial Extracorporeal Membrane Oxygenation: Associations with In-Hospital Mortality. Journal of Cardiovascular Development and Disease, 13(11), 583. https://doi.org/10.3390/jcdd13110583
Vancouver
Tekin G, Demirbaş ZE, Elçi ME, Yılmaz Ş. Ischemic Hepatitis Before and During Venoarterial Extracorporeal Membrane Oxygenation: Associations with In-Hospital Mortality. Journal of Cardiovascular Development and Disease. 2026;13(11):583. doi:10.3390/jcdd13110583
BibTeX
@article{Tekin2026,
author = {Tekin, Gözde and Demirbaş, Zeynep Ece and Elçi, Mehmet Emre and Yılmaz, Şahin},
title = {Ischemic Hepatitis Before and During Venoarterial Extracorporeal Membrane Oxygenation: Associations with In-Hospital Mortality},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {11},
pages = {583},
doi = {10.3390/jcdd13110583}
}
EUVIMED